Summary of ALLERGAN INC - Yahoo! Finance

Item 5.07. Submission of Matters to a Vote of Security Holders.

Allergan, Inc. (the "Company") held its Annual Meeting of Stockholders on May 1, 2012 (the "Annual Meeting") and there were present in person or by proxy 270,114,143 votes, representing approximately 88.6% of the Company's 304,714,456 total outstanding eligible votes. At the Annual Meeting, the Company's stockholders (i) elected ten directors to the Company's board of directors;
(ii) ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2012; (iii) approved the compensation of the Company's named executive officers; and (iv) and approved a non-binding stockholder proposal, each as more fully described below.

                                                                                                Broker
                                                For             Against         Abstain       Non-Votes
Item No. 1: Election of the following
ten directors to serve for a term of
office expiring at the 2013 annual
meeting of stockholders and until their
successors are duly elected and
qualified:

David E.I. Pyott                             243,744,825        14,188,026       305,487       11,875,805
Herbert W. Boyer, Ph.D.                      254,000,497         4,014,536       223,305       11,875,805
Deborah Dunsire, M.D.                        256,205,236         1,831,802       201,300       11,875,805
Michael R. Gallagher                         250,004,353         8,007,031       226,954       11,875,805
Dawn Hudson                                  248,832,556         9,143,897       261,885       11,875,805
Robert A. Ingram                             243,019,028        14,876,387       342,923       11,875,805
Trevor M. Jones, Ph.D.                       255,490,135         2,415,394       332,809       11,875,805
Louis J. Lavigne, Jr.                        255,979,928         2,004,680       253,730       11,875,805
Russell T. Ray                               251,930,186         5,990,386       317,766       11,875,805
Stephen J. Ryan, M.D.                        256,003,992         1,997,007       237,339       11,875,805

Item No. 2: Ratification of the
appointment of Ernst & Young LLP as the
Company's independent registered public
accounting firm for fiscal year 2012 269,444,195 485,904 184,044 0

Item No. 3: Advisory vote to approve the
compensation of the Company's named
executive officers 230,266,686 27,156,176 815,476 11,875,805

Item No. 4: Stockholder proposal
(special stockholder meetings) 142,545,778 115,252,470 440,090 11,875,805